As progenitor developmental stages of AML, these populations should also be present in vitro, which has been demonstrated by Lica and Pradhan (2023), who identified VSLSLCs and SLSLCs populations within HL60 cultures, distinguished by their size and CD34 expression. Here, CD34 is linked to acute myeloid leukemia.